Industry News

Drug and Alcohol Testing

December 08, 2023

As of January 1, 2024, California will introduce the AB 2188 update. This legislative update significantly alters the landscape for employers, shaping how they approach hiring, termination, and other critical employment decisions based on cannabis use. Jennifer Mora, Senior Counsel at Seyfarth Shaw LLP, recently discussed these updates in a recent webinar presentation for DISA, followed by a Q&A session offering further insights into the intricacies of AB 2188 and the challenges it presents for employers navigating California’s evolving legal framework. Here are some of the most commonly asked questions regarding AB 2188.

Background Check

December 07, 2023

Updated 12/1/2023 | In today's professional landscape, pre-employment background checks are a crucial component for many companies. These screenings ensure the integrity, qualifications, and history of prospective employees. While some companies may choose to handle these background checks in-house, a growing number of firms are opting for the expertise and efficiency of consumer reporting agencies (CRA). To aid your search in finding the ideal partner tailored to your organization's needs and budget, we've compiled a list of the leading background check service providers this year.

Transportation Compliance

November 13, 2023

Beginning January 1, 2024, access to the DOT’s drug and alcohol MIS (DAMIS) will transition to Login.gov. As part of the transition, Login.gov requires multifactor authentication, which removes the ability for TPAs to submit this content for customers. Submissions must now be completed by the DOT-regulated employers themselves.

Drug and Alcohol Testing

November 10, 2023

On November 7, 2023, Ohio voters passed Ohio Issue 2, Marijuana Legalization Initiative (Issue 2), legalizing recreational cannabis in the state. Issue 2 is a voter initiative, meaning that the legislature may still choose to adjust or, in rare cases, even repeal the initiative.

Drug and Alcohol Testing

November 09, 2023

The world of illicit drugs has seen a shift largely driven by the emergence of fentanyl. Allen Johnson, VP of Marketing, Psychemedics, recently presented a webinar for DISA covering the essential information about fentanyl followed by Q&A with attendees. Here are some of the most common questions Allen sees on the topic.

Background Check

November 06, 2023

DISA Global Solutions is excited to share a remarkable achievement with our clients and partners: the successful completion of the 3-year interim surveillance audit under the Professional Background Screening Association (PBSA). This milestone is a testament to our unwavering commitment to excellence, compliance, and the highest professional standards in the background screening industry.

Drug and Alcohol Testing

November 03, 2023

The world of illicit drugs has seen a shift largely driven by the emergence of fentanyl. This blog will guide you through the myths and truths surrounding fentanyl and testing methods that will appropriately find fentanyl. Allen Johnson, VP of Marketing, Psychemedics, recently presented a webinar for DISA covering the essential and need-to-know information about fentanyl.  Here’s a summary of everything he discussed.